| J9271 | Injection, pembrolizumab, 1 mg | 12,800 | $40 | $550.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 600 | $110 | $63.5K |
| J0897 | Injection, denosumab, 1 mg | 3,120 | $20 | $59.3K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 39,750 | $1 | $39.8K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,120 | $10 | $30.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 380 | $70 | $27.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 230 | $120 | $27K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,940 | $10 | $11.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 70 | $160 | $10.2K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 60 | $150 | $8.4K |